|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
|
CA2686827C
(en)
|
2006-12-14 |
2014-09-16 |
Aileron Therapeutics, Inc. |
Bis-sulfhydryl macrocyclization systems
|
|
PT2118123E
(pt)
|
2007-01-31 |
2016-02-10 |
Harvard College |
Péptidos de p53 estabilizados e suas utilizações
|
|
AU2008218116B2
(en)
|
2007-02-23 |
2012-04-05 |
Aileron Therapeutics, Inc. |
Triazole macrocycle systems
|
|
ES2430067T3
(es)
*
|
2007-03-28 |
2013-11-18 |
President And Fellows Of Harvard College |
Polipéptidos cosidos
|
|
WO2010011313A2
(en)
*
|
2008-07-23 |
2010-01-28 |
President And Fellows Of Harvard College |
Ligation of stapled polypeptides
|
|
AU2009294877C1
(en)
|
2008-09-22 |
2015-05-07 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US9458202B2
(en)
|
2008-11-24 |
2016-10-04 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles with improved properties
|
|
AU2010204648B2
(en)
|
2009-01-14 |
2016-09-01 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US9163330B2
(en)
|
2009-07-13 |
2015-10-20 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
|
EP2480565A4
(en)
|
2009-09-22 |
2014-01-01 |
Aileron Therapeutics Inc |
PEPTIDOMIMETIC MACROCYCLES
|
|
WO2012021874A1
(en)
|
2010-08-13 |
2012-02-16 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles with thioether linkers
|
|
US8957026B2
(en)
|
2010-09-22 |
2015-02-17 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
|
US9428845B1
(en)
|
2010-12-28 |
2016-08-30 |
Warp Drive Bio, Inc. |
Identifying new therapeutic agents
|
|
CN103501805B
(zh)
|
2011-01-18 |
2018-09-14 |
比奥尼斯有限责任公司 |
调节γ-C-细胞因子活性的组合物及方法
|
|
CN103415530A
(zh)
*
|
2011-03-09 |
2013-11-27 |
Jitsubo株式会社 |
新型的含有非肽性交联结构的交联肽、以及该交联肽的合成方法和用于该方法的新型有机化合物
|
|
US10703785B2
(en)
*
|
2011-04-15 |
2020-07-07 |
Dana-Farber Cancer Institute, Inc. |
Targeting deregulated Wnt signaling in cancer using stabilized alpha-helices of BCL-9
|
|
US20120302503A1
(en)
*
|
2011-05-23 |
2012-11-29 |
AML Therapeutics, LLC |
PEPTIDES FOR PREVENTING OR TREATING A DISEASE OR DISORDER ASSOCIATED WITH CBP OR p300 MISREGULATION, AND METHODS FOR USE AND IDENTIFICATION THEREOF
|
|
US9120040B2
(en)
*
|
2011-05-26 |
2015-09-01 |
The University Of Akron |
Anti-fouling materials based on poly(β-peptoid)s
|
|
US9487562B2
(en)
|
2011-06-17 |
2016-11-08 |
President And Fellows Of Harvard College |
Stabilized polypeptides as regulators of RAB GTPase function
|
|
BR112014009418A2
(pt)
|
2011-10-18 |
2017-04-18 |
Aileron Therapeutics Inc |
macrociclos peptidomiméticos
|
|
MX358660B
(es)
*
|
2012-01-12 |
2018-08-30 |
Univ Yale |
Compuestos y metodos para degradacion mejorada de proteinas y otros polipeptidos elegidos como blanco mediante una ubiquitina ligasa e3.
|
|
EP2819688A4
(en)
|
2012-02-15 |
2015-10-28 |
Aileron Therapeutics Inc |
TRIAZOL AND THIOETHER-COUPLED PEPTIDOMIMETIC MACROCYCLES
|
|
AU2013221432B2
(en)
|
2012-02-15 |
2018-01-18 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
PT2920197T
(pt)
|
2012-09-26 |
2021-06-11 |
Harvard College |
Péptidos agrafados com bloqueio de prolina e suas utilizações
|
|
JP6526563B2
(ja)
|
2012-11-01 |
2019-06-05 |
エイルロン セラピューティクス，インコーポレイテッド |
二置換アミノ酸ならびにその調製および使用の方法
|
|
EA027908B1
(ru)
|
2012-12-21 |
2017-09-29 |
Эпизим, Инк. |
Ингибиторы prmt5 и их применения
|
|
WO2014138429A2
(en)
|
2013-03-06 |
2014-09-12 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and use thereof in regulating hif1alpha
|
|
AU2014244232B2
(en)
|
2013-03-13 |
2019-05-02 |
President And Fellows Of Harvard College |
Stapled and stitched polypeptides and uses thereof
|
|
EP3572422A1
(en)
*
|
2013-03-15 |
2019-11-27 |
Dana-Farber Cancer Institute, Inc. |
Bh4 stabilized peptides and uses thereof
|
|
US10308926B2
(en)
|
2013-03-15 |
2019-06-04 |
Dana-Farber Cancer Institute, Inc. |
Stablized EZH2 peptides
|
|
US10227390B2
(en)
*
|
2013-06-14 |
2019-03-12 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
|
GB201311891D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compound
|
|
GB201311888D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
DK3019619T3
(da)
|
2013-07-11 |
2021-10-11 |
Modernatx Inc |
Sammensætninger, der omfatter syntetiske polynukleotider, som koder for crispr-beslægtede proteiner, og syntetiske sgrna'er, og anvendelsesfremgangsmåder
|
|
US9365615B2
(en)
|
2013-09-09 |
2016-06-14 |
Jitsubo Co., Ltd. |
Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
|
|
JP2017503749A
(ja)
*
|
2013-10-01 |
2017-02-02 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
安定化されたポリペプチドおよびその使用
|
|
RU2738833C9
(ru)
*
|
2014-04-14 |
2022-02-28 |
Арвинас, Оперэйшнз, Инк. |
Имидные модуляторы протеолиза и способы их применения
|
|
WO2015179635A2
(en)
|
2014-05-21 |
2015-11-26 |
President And Fellows Of Harvard College |
Ras inhibitory peptides and uses thereof
|
|
US10071164B2
(en)
|
2014-08-11 |
2018-09-11 |
Yale University |
Estrogen-related receptor alpha based protac compounds and associated methods of use
|
|
CA2961258A1
(en)
|
2014-09-24 |
2016-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
EP3197477A4
(en)
|
2014-09-24 |
2018-07-04 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and formulations thereof
|
|
TW201629069A
(zh)
|
2015-01-09 |
2016-08-16 |
霍普驅動生物科技股份有限公司 |
參與協同結合之化合物及其用途
|
|
EP3247378B8
(en)
|
2015-01-09 |
2023-08-23 |
Revolution Medicines, Inc. |
Macrocyclic compounds that participate in cooperative binding and medical uses thereof
|
|
US20170327469A1
(en)
|
2015-01-20 |
2017-11-16 |
Arvinas, Inc. |
Compounds and methods for the targeted degradation of androgen receptor
|
|
KR20230119040A
(ko)
|
2015-01-20 |
2023-08-14 |
아비나스 오퍼레이션스, 인코포레이티드 |
안드로겐 수용체의 표적화된 분해를 위한 화합물 및방법
|
|
WO2016123443A1
(en)
*
|
2015-01-29 |
2016-08-04 |
Trustees Of Boston University |
Method and composition for reducing nitrates, nitrites, and/or hydroxylamine in water using a homogeneous reduced copper tetra-substituted fluorinated pinacolate ligand catalyst complex
|
|
US10730870B2
(en)
|
2015-03-18 |
2020-08-04 |
Arvinas Operations, Inc. |
Compounds and methods for the enhanced degradation of targeted proteins
|
|
CN107614003A
(zh)
|
2015-03-20 |
2018-01-19 |
艾瑞朗医疗公司 |
拟肽大环化合物及其用途
|
|
WO2016172187A1
(en)
*
|
2015-04-20 |
2016-10-27 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Methods and compositions related to kras inhibitors
|
|
EP3302482A4
(en)
|
2015-06-05 |
2018-12-19 |
Arvinas, Inc. |
Tank-binding kinase-1 protacs and associated methods of use
|
|
WO2016209978A2
(en)
*
|
2015-06-22 |
2016-12-29 |
University Of Utah Research Foundation |
Thiol-ene based peptide stapling and uses thereof
|
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
|
US20170008904A1
(en)
*
|
2015-07-10 |
2017-01-12 |
Arvinas, Inc. |
Mdm2-based modulators of proteolysis and associated methods of use
|
|
EP3337476A4
(en)
|
2015-08-19 |
2019-09-04 |
Arvinas, Inc. |
COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF PROTEINS CONTAINING BROMODOMAIN
|
|
JP2018528217A
(ja)
|
2015-09-10 |
2018-09-27 |
エルロン・セラピューティクス・インコーポレイテッドＡｉｌｅｒｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
Ｍｃｌ−１のモジュレーターとしてのペプチド模倣大環状分子
|
|
CA3000822A1
(en)
|
2015-10-01 |
2017-04-06 |
Warp Drive Bio, Inc. |
Methods and reagents for analyzing protein-protein interfaces
|
|
KR20180097530A
(ko)
|
2015-11-02 |
2018-08-31 |
예일 유니버시티 |
단백질분해 표적화 키메라 화합물(Proteolysis Targeting Chimera compound) 및 그의 제조 및 사용 방법
|
|
US10011631B2
(en)
*
|
2015-12-01 |
2018-07-03 |
The University Of Hong Kong |
Stapled helical peptides and methods of synthesis
|
|
KR102479601B1
(ko)
|
2015-12-21 |
2022-12-22 |
텍사스 테크 유니버시티 시스템 |
용액상 gap 펩타이드 합성을 위한 시스템 및 방법
|
|
GB2545898B
(en)
*
|
2015-12-21 |
2019-10-09 |
Sutura Therapeutics Ltd |
Improved drug delivery by conjugating oligonucleotides to stitched/stapled peptides
|
|
US20190365913A1
(en)
*
|
2016-02-04 |
2019-12-05 |
Tarveda Therapeutics, Inc. |
Stapled peptide conjugates and particles
|
|
EP3442599B1
(en)
|
2016-04-12 |
2022-03-30 |
Warp Drive Bio, Inc. |
Compositions and methods for the production of compounds
|
|
US20190135868A1
(en)
*
|
2016-04-29 |
2019-05-09 |
The University Of Chicago |
Synthetic dna binding domain peptides and uses thereof
|
|
CA3025806C
(en)
*
|
2016-06-23 |
2023-04-04 |
Dana-Farber Cancer Institute, Inc. |
Degradation of bromodomain-containing protein 9 (brd9) by conjugation of brd9 inhibitors with e3 ligase ligand and methods of use
|
|
WO2017223415A1
(en)
*
|
2016-06-23 |
2017-12-28 |
Dana-Farber Cancer Institute, Inc. |
Degradation of tripartite motif-containing protein 24 (trim24) by conjugation of trim24 inhibitors with e3 ligase ligand and methods of use
|
|
WO2018017485A1
(en)
|
2016-07-17 |
2018-01-25 |
University Of Utah Research Foundation |
Thiol-yne based peptide stapling and uses thereof
|
|
WO2018039545A2
(en)
|
2016-08-26 |
2018-03-01 |
Dana-Farber Cancer Institute, Inc. |
Bcl-w polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss
|
|
US20180072711A1
(en)
|
2016-09-15 |
2018-03-15 |
Arvinas, Inc. |
Indole derivatives as estrogen receptor degraders
|
|
HRP20230414T1
(hr)
|
2016-10-11 |
2023-07-07 |
Arvinas Operations, Inc. |
Spojevi i postupci za ciljanu razgradnju androgenog receptora
|
|
CA3042231A1
(en)
|
2016-10-28 |
2018-05-03 |
Ginkgo Bioworks, Inc. |
Compositions and methods for the production of compounds
|
|
IL290809B2
(en)
|
2016-11-01 |
2024-01-01 |
Arvinas Operations Inc |
PROTACS Targeted Tau-Protein and Related Methods of Use
|
|
US11208446B2
(en)
|
2016-11-01 |
2021-12-28 |
Memorial Sloan Kettering Cancer Cenier |
Agents and methods for treating CBP-dependent cancers
|
|
KR102173464B1
(ko)
|
2016-12-01 |
2020-11-04 |
아비나스 오퍼레이션스, 인코포레이티드 |
에스트로겐 수용체 분해제로서의 테트라히드로나프탈렌 및 테트라히드로이소퀴놀린 유도체
|
|
US11173211B2
(en)
|
2016-12-23 |
2021-11-16 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of rapidly accelerated Fibrosarcoma polypeptides
|
|
EP3559006A4
(en)
|
2016-12-23 |
2021-03-03 |
Arvinas Operations, Inc. |
COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF FETAL LIVER KINASE POLYPEPTIDES
|
|
MX2019007649A
(es)
|
2016-12-23 |
2019-09-10 |
Arvinas Operations Inc |
Compuestos y metodos para la degradacion dirigida de polipeptidos de fibrosarcoma acelerado rapidamente.
|
|
EP3559002A4
(en)
|
2016-12-23 |
2021-02-17 |
Arvinas Operations, Inc. |
CHEMERICAL MOLECULES TARGETING EGFR PROTEOLYSIS AND RELATED METHODS OF USE
|
|
US11191741B2
(en)
|
2016-12-24 |
2021-12-07 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
|
|
CA3049912A1
(en)
|
2017-01-26 |
2018-08-02 |
Arvinas Operations, Inc. |
Modulators of estrogen receptor proteolysis and associated methods of use
|
|
JP2020506922A
(ja)
*
|
2017-01-31 |
2020-03-05 |
アルビナス・オペレーションズ・インコーポレイテッドＡｒｖｉｎａｓ Ｏｐｅｒａｔｉｏｎｓ， Ｉｎｃ． |
セレブロンリガンド、およびセレブロンリガンドを含有する二官能性化合物
|
|
CN110506050A
(zh)
*
|
2017-04-07 |
2019-11-26 |
比奥尼斯有限责任公司 |
γC细胞因子活性的稳定调节剂
|
|
CN111372942A
(zh)
*
|
2017-09-07 |
2020-07-03 |
弗格制药有限公司 |
调节β-联蛋白功能的物质及其方法
|
|
US11065231B2
(en)
|
2017-11-17 |
2021-07-20 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides
|
|
CN112119085A
(zh)
|
2017-12-15 |
2020-12-22 |
丹娜-法伯癌症研究院有限公司 |
稳定肽-介导的靶向蛋白降解
|
|
CN108129553B
(zh)
*
|
2018-01-05 |
2020-12-08 |
杭州端丽生物技术有限公司 |
防治端粒功能异常相关疾病的多肽及医药用途
|
|
WO2019148055A1
(en)
|
2018-01-26 |
2019-08-01 |
Yale University |
Imide-based modulators of proteolysis and methods of use
|
|
US11952432B2
(en)
|
2018-02-07 |
2024-04-09 |
Dana-Farber Cancer Institute, Inc. |
Cell-permeable stapled peptide modules for cellular delivery
|
|
MX2020010420A
(es)
|
2018-04-04 |
2020-12-11 |
Arvinas Operations Inc |
Moduladores de la proteólisis y métodos asociados de uso.
|
|
WO2019231760A1
(en)
*
|
2018-05-31 |
2019-12-05 |
Gap Peptides Llc |
Method for solution-phase peptide synthesis and protecting strategies therefore
|
|
WO2020023502A1
(en)
|
2018-07-23 |
2020-01-30 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and uses thereof
|
|
CN112912376A
(zh)
|
2018-08-20 |
2021-06-04 |
阿尔维纳斯运营股份有限公司 |
用于治疗神经变性疾病的具有E3泛素连接酶结合活性并靶向α-突触核蛋白的蛋白水解靶向嵌合(PROTAC)化合物
|
|
KR20210118816A
(ko)
|
2018-12-19 |
2021-10-01 |
셀진 코포레이션 |
치환된 3-((3-아미노페닐)아미노)피페리딘-2,6-디온 화합물, 이의 조성물, 및 이를 사용한 치료 방법
|
|
WO2020132016A1
(en)
|
2018-12-19 |
2020-06-25 |
Celgene Corporation |
Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith
|
|
CA3125912A1
(en)
*
|
2019-01-07 |
2020-07-16 |
University Of Washington |
De novo design of protein switches for tunable control of protein degradation
|
|
US11827660B2
(en)
|
2019-02-01 |
2023-11-28 |
Sederma |
Synthesis strategy for gap protecting group
|
|
US20220160890A1
(en)
*
|
2019-02-21 |
2022-05-26 |
Locki Therapeutics Limited |
Survival-targeting chimeric (surtac) molecules
|
|
WO2020191369A1
(en)
|
2019-03-21 |
2020-09-24 |
Codiak Biosciences, Inc. |
Process for preparing extracellular vesicles
|
|
JP2022525924A
(ja)
|
2019-03-21 |
2022-05-20 |
コディアック バイオサイエンシーズ， インコーポレイテッド |
細胞外小胞コンジュゲート及びその使用
|
|
JP2022540935A
(ja)
|
2019-07-17 |
2022-09-20 |
アルビナス・オペレーションズ・インコーポレイテッド |
タウタンパク質標的化化合物および関連する使用方法
|
|
US11345725B2
(en)
|
2019-09-16 |
2022-05-31 |
Research Foundation Of The City University Of New York |
Bis-thioether stapled peptides as inhibitors of PRC2 function
|
|
WO2021091967A1
(en)
|
2019-11-04 |
2021-05-14 |
Revolution Medicines, Inc. |
Ras inhibitors
|
|
KR20220109407A
(ko)
|
2019-11-04 |
2022-08-04 |
레볼루션 메디슨즈, 인크. |
Ras 억제제
|
|
AU2020379734A1
(en)
|
2019-11-04 |
2022-05-05 |
Revolution Medicines, Inc. |
Ras inhibitors
|
|
CN110687304A
(zh)
*
|
2019-11-21 |
2020-01-14 |
徐州医科大学 |
检测ezh2的r342位点非对称性二甲基化修饰的抗体
|
|
PE20221582A1
(es)
|
2019-12-19 |
2022-10-06 |
Arvinas Operations Inc |
Compuestos y metodos para la degradacion dirigida de receptor de androgenos
|
|
CA3164578A1
(en)
*
|
2020-01-14 |
2021-07-22 |
Scott KANNER |
Compositions and methods for targeted protein stabilization by redirecting endogenous deubiquitinases
|
|
WO2021163467A1
(en)
*
|
2020-02-14 |
2021-08-19 |
Temple University-Of The Commonwealth System Of Higher Education |
Linking amino acid sequences, manufacturing method thereof, and use thereof
|
|
WO2021237100A1
(en)
|
2020-05-21 |
2021-11-25 |
Codiak Biosciences, Inc. |
Methods of targeting extracellular vesicles to lung
|
|
US20230279405A1
(en)
*
|
2020-07-24 |
2023-09-07 |
University Of Massachusetts |
Dna-binding domain transactivators and uses thereof
|
|
US11690915B2
(en)
|
2020-09-15 |
2023-07-04 |
Revolution Medicines, Inc. |
Ras inhibitors
|
|
WO2022066928A2
(en)
|
2020-09-23 |
2022-03-31 |
Codiak Biosciences, Inc. |
Process for preparing extracellular vesicles
|
|
AU2021360898A1
(en)
|
2020-10-14 |
2023-03-23 |
Dana-Farber Cancer Institute, Inc. |
Chimeric conjugates for degradation of viral and host proteins and methods of use
|
|
EP4063380A1
(en)
*
|
2021-03-24 |
2022-09-28 |
Stichting VU |
Inhibitors of the wnt signaling pathway and uses thereof
|
|
JP2024515619A
(ja)
|
2021-04-16 |
2024-04-10 |
アルビナス・オペレーションズ・インコーポレイテッド |
Ｂｃｌ６タンパク質分解の調節因子および関連する使用方法
|
|
CN114836503B
(zh)
*
|
2022-04-29 |
2023-08-25 |
江苏祈瑞医药科技有限公司 |
一组具有肝损伤保护作用的乳清蛋白肽、高f值寡肽及其制备方法和应用
|
|
WO2024054591A1
(en)
|
2022-09-07 |
2024-03-14 |
Arvinas Operations, Inc. |
Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of use
|
|
WO2024051616A1
(zh)
*
|
2022-09-09 |
2024-03-14 |
湖南大学 |
一种多肽及其制备方法和用途
|
|
CN117603330B
(zh)
*
|
2023-04-23 |
2024-04-16 |
山东第一医科大学(山东省医学科学院) |
订书肽、其制备方法和应用
|